An industrial production method for dibromocyanoacetamide solution
By employing high-temperature homogeneous continuous bromination reaction and mother liquor purification and reuse, the problems of low bromine utilization and equipment corrosion in DBNPA production have been solved, achieving efficient and environmentally friendly production of dibromocyanoacetamide and ensuring product quality stability and continuous operation.
Patent Information
- Application Number
- CN202611287089.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-24
- Publication Date
- 2026-11-17
AI Technical Summary
The existing industrial production of dibromocyanoacetamide (DBNPA) suffers from problems such as low bromine utilization, byproduct hydrobromic acid leading to equipment corrosion and environmental pollution, accumulation of inorganic salt byproducts hindering mother liquor reuse, and low efficiency and poor batch consistency in intermittent production.
A high-temperature homogeneous continuous bromination reaction is adopted, and hydrogen peroxide is used to oxidize the by-product hydrobromic acid into bromine in situ, realizing the closed-loop recycling of bromine. Combined with rapid cooling crystallization and mother liquor purification and reuse, high-efficiency production is achieved through a multi-stage tubular reactor and an online control system.
It improves bromine utilization to nearly 100%, significantly reduces raw material consumption and waste acid emissions, shortens reaction time, improves production efficiency, ensures product quality stability and continuous operation reliability, and achieves near-zero wastewater discharge.
Abstract
Description
Technical Field
[0001] This invention belongs to the field of green synthesis technology in fine chemicals, and specifically relates to an industrial production method of dibromocyanoacetamide solution. Background Technology
[0002] Dibromocyanoacetamide (DBNPA) is a broad-spectrum bactericide widely used for microbial control in industrial circulating cooling water, oilfield reinjection water, paper pulp corrosion prevention, and coating mildew prevention.
[0003] Currently, the industrial production of DBNPA mainly employs a batch process involving the electrophilic bromination reaction of cyanoacetamide (CAA) and bromine in an acidic aqueous phase at 0–10°C. In this process, each mole of cyanoacetamide reacts with two moles of bromine (Br2) to produce one mole of DBNPA, while simultaneously producing two moles of hydrobromic acid (HBr) as a byproduct. The bromine atom utilization rate is only about 50%. The byproduct HBr is highly corrosive, exacerbating equipment wear and tear, and the bromine-containing wastewater requires additional neutralization treatment, increasing the environmental disposal burden.
[0004] Some processes attempt to introduce oxidants to regenerate HBr into Br2 for recycling. However, limitations exist due to the low mass transfer efficiency of the solid-liquid heterogeneous system, lag in oxidation kinetics, and the continuous accumulation of inorganic salts such as NaBr and NaCl in the mother liquor, making effective reuse of the mother liquor difficult and hindering continuous process operation. Furthermore, most commercially available DBNPA formulations use lower alcohols as solvents, leading to pH decreases during long-term storage due to hydrolysis and HBr precipitation, resulting in insufficient product stability. Intermittent operation involves long reaction cycles and significant batch-to-batch product quality fluctuations, making it difficult to meet the quality consistency requirements of large-scale continuous production.
[0005] Therefore, there is an urgent need to develop a continuous industrial production method for dibromocyanoacetamide that features high bromine utilization, recyclable mother liquor, and stable and controllable product quality. Summary of the Invention
[0006] This invention addresses the technical shortcomings of existing industrial production technologies for dibromocyanoacetamide, such as low bromine utilization efficiency, equipment corrosion and environmental pollution caused by byproduct hydrobromic acid, accumulation of inorganic salt byproducts hindering mother liquor reuse, and low efficiency and poor batch consistency in intermittent production. It provides an industrial production method for dibromocyanoacetamide solution.
[0007] To achieve the above objectives, the technical solution adopted by the present invention is as follows:
[0008] An industrial method for producing a dibromocyanoacetamide solution includes the following steps:
[0009] S1 Raw Material Pre-dissolution: Dissolve cyanoacetamide in water to prepare a pre-solution with a mass concentration of 20% to 30%;
[0010] S2 High-Temperature Homogeneous Continuous Bromination Reaction: The pre-solution, liquid bromine, and hydrogen peroxide aqueous solution are simultaneously and continuously injected into a tubular reactor, and the bromination reaction is carried out under homogeneous aqueous solution conditions at 70–87°C. The molar amount of liquid bromine added is 1.0–1.3 times the molar amount of cyanoacetamide, and the amount of liquid bromine added is the net amount after deducting the amount of bromine recovered from in-situ oxidation and regeneration by hydrogen peroxide. The molar amount of hydrogen peroxide added is 1.0–1.1 times the amount of byproduct hydrobromic acid theoretically required for consumption. The tubular reactor includes a first heating zone, a second heating zone, and a third heating zone arranged sequentially along the axial direction. The temperature of the first heating zone is 70–80°C, the temperature of the second heating zone is 83–87°C, and the temperature of the third heating zone is 78–85°C. During the reaction, hydrogen peroxide in-situ oxidizes and regenerates the byproduct hydrobromic acid into bromine, achieving a closed-loop bromine cycle. The total residence time of the reaction is 60–90 minutes.
[0011] S3 Rapid Cooling Crystallization: The high-temperature clarified liquid after the reaction is completed is subjected to two-stage cooling treatment: first, it is initially cooled to 55-65℃ by a heat exchanger, and then rapidly cooled from 55-65℃ to 18-22℃ within 15-25 seconds. The cooling rate of the rapid cooling stage is 1.5-3.0℃ / s, which induces the selective crystallization of dibromocyanoacetamide.
[0012] S4 Centrifugation and Drying: The crystallized slurry is centrifuged to separate the solid and liquid components, and wet dibromocyanoacetamide is obtained. After washing and drying, a solid product is obtained.
[0013] S5 Mother liquor purification and recycling: The mother liquor obtained by centrifugation is purified by microfiltration and resin adsorption in sequence and then divided into two parts. The first part is recycled for the pre-dissolution of raw materials in the next batch of step S1 and the reaction medium in step S2; the second part is used for the preparation of solution formulation in step S6.
[0014] S6 Solution Formulation Preparation: Take the DBNPA solid product obtained in step S4, dissolve it in the purified circulating mother liquor after step S5, add a composite co-solvent and a stabilizer, and prepare a solution formulation; the composite co-solvent is composed of polyethylene glycol 400 and dipropylene glycol mixed in a mass ratio of (1.5~2.5):1, and the total amount added is 15%~20% of the mass of dibromocyanoacetamide; the stabilizer is sodium benzoate, and the amount added is 0.05%~0.2% of the total mass of the formulation.
[0015] Preferably, the temperature of the first heating zone is 75°C, the temperature of the second heating zone is 85±2°C, and the temperature of the third heating zone is 82°C; the length of the first heating zone accounts for 25% to 35% of the total length of the reactor, the length of the second heating zone accounts for 35% to 45%, and the length of the third heating zone accounts for 25% to 35%.
[0016] Preferably, in step S2, the hydrogen peroxide is added in the form of an aqueous solution with a mass concentration of 25% to 35%, using a gradient batch injection method: in the first stage, 35% to 45% of the total feed amount is added within 5 to 15 minutes after the reaction starts, and after the exothermic reaction tends to stabilize, the remaining part is added in a linear increment within 30 to 50 minutes in the second stage.
[0017] Preferably, in step S3, the rapid cooling crystallization adopts a dynamic cooling system consisting of a plate heat exchanger and a spiral coil cooling device connected in series; the high-temperature reaction liquid is first cooled to 55-65°C by the plate heat exchanger, and then rapidly cooled to 18-22°C by the spiral coil cooling device under the action of chilled brine; the Reynolds number Re of the fluid in the tube is >8000.
[0018] Preferably, in step S3, by controlling the cooling rate and supersaturation, the median particle size D50 of the obtained dibromocyanoacetamide crystals is 80-120 μm, and the particle size distribution coefficient Span < 1.2.
[0019] Preferably, in step S5, the microporous filtration uses a microporous filter membrane with a pore size of 0.2 to 0.8 μm; the resin adsorption uses a strongly basic anion exchange resin; the pH of the circulating mother liquor is controlled at 5.0 to 6.5, and the total organic carbon content fluctuates by less than ±5%; the mother liquor supports continuous recycling for at least 10 batches.
[0020] Preferably, the mass ratio of polyethylene glycol 400 to dipropylene glycol is 2:1, and the total amount added is 18% of the mass of dibromocyanoacetamide; the amount of sodium benzoate added is 0.1% of the total mass of the preparation; and the effective dibromocyanoacetamide content in the resulting solution preparation is 12% to 18%.
[0021] Preferably, the inner wall of the tubular reactor is made of 316L stainless steel, titanium, or enamel, with a surface roughness Ra≤0.8μm; the reactor is equipped with spiral guide vanes; and a temperature buffer transition section is provided between each heating zone.
[0022] Preferably, the entire process is integrated and managed by a PLC control system, which forms a closed-loop feedback control loop through online temperature sensors, flow meters, pH meters, conductivity meters, UV detectors, dissolved oxygen sensors, and pressure transmitters to achieve precise and coordinated control of temperature, flow rate, feed ratio, cooling rate, and mother liquor composition.
[0023] In an acidic aqueous phase at 70–87 °C, cyanoacetamide, liquid bromine, and the product dibromocyanoacetamide all have sufficient solubility to ensure that the reaction system is homogeneous and to eliminate solid-liquid mass transfer resistance.
[0024] Beneficial Effects: This invention regenerates byproduct hydrobromic acid into active bromine through in-situ oxidation with hydrogen peroxide, achieving a closed-loop recycling of bromine with a total utilization rate approaching 100%, significantly reducing raw material consumption and waste acid emissions. The high-temperature homogeneous continuous reaction process enhances mass and heat transfer, shortening the reaction time to less than 1.5 hours and greatly improving production efficiency. The rapid cooling crystallization process yields crystals with a concentrated particle size distribution, facilitating separation and improving product purity and yield. The purified mother liquor is recycled to avoid inorganic salt accumulation, supporting continuous operation for at least 10 batches with near-zero wastewater discharge. The gradient addition of hydrogen peroxide in batches effectively controls reaction risks and enhances process safety. The purified mother liquor is used directly to prepare solution formulations, saving energy and ensuring excellent storage stability of the formulations. The overall process is highly automated, produces no salt-containing byproducts, and meets clean production requirements. Detailed Implementation
[0025] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to specific embodiments. The following embodiments are used to illustrate the invention but are not intended to limit the scope of protection of the invention. Any modifications, equivalent substitutions, and improvements made to the method of this invention without departing from the spirit and essence of the invention should be included within the scope of protection of this invention.
[0026] Example 1
[0027] This embodiment provides an industrial production method for dibromocyanoacetamide solution, specifically including the following steps:
[0028] S1 Raw Material Pre-dissolution: Weigh 250 kg of industrial-grade cyanoacetamide with a purity ≥99.0%, add it to 750 kg of deionized water, and dissolve it at room temperature (25°C) for 30 minutes under stirring to prepare a cyanoacetamide pre-solution with a mass concentration of 25%. After filtering the pre-solution through a 100-mesh stainless steel filter, it is delivered to the feed inlet of the first heating zone of the multi-stage series tubular reactor at a constant flow rate of 50 L / min via a diaphragm metering pump.
[0029] S2 High-Temperature Homogeneous Continuous Bromination Reaction: The tubular reactor is a stainless steel tubular reactor with an inner diameter of 150 mm and a total length of 12 m, and the inner wall is electrolytically polished. The reactor is divided into three independently temperature-controlled heating zones along the axial direction: the first heating zone, located at the front, is 3.6 m long and uses a heat transfer oil circulation jacket for heating, with a temperature control of 75±1℃; the second heating zone, located in the middle, is 4.8 m long and uses an electric heating belt combined with an infrared temperature feedback system, with a temperature control of 85±2℃; the third heating zone, located at the end, is 3.6 m long and uses a heat transfer oil circulation jacket for heating, with a temperature control of 82±1℃. A 100 mm long temperature buffer transition section is provided between each heating zone. Spiral guide vanes with a pitch of 200 mm are welded axially inside the reactor to guide the material forward in a spiral shape, enhancing radial mixing.
[0030] A high-precision Coriolis mass flow meter and metering pump are used to simultaneously and continuously inject liquid bromine with a purity ≥99.7% and a 30% hydrogen peroxide aqueous solution into the feed inlet of the first heating zone of the reactor. The molar dosage of liquid bromine is 1.2 times the molar dosage of cyanoacetamide, i.e., 1.2 moles of liquid bromine are added for every mole of cyanoacetamide. The molar dosage of H2O2 is 1.05 times the amount required to theoretically consume the byproduct HBr, i.e., 1.05 moles of H2O2 are added for every 2 moles of HBr. H2O2 is injected in a gradient batch manner: in the first stage, 40% of the total feed is added within 10 minutes after the reaction starts to oxidize the initially generated HBr and maintain the free bromine concentration in the system; after the temperature rise rate of the jacket circuit drops to <0.5℃ / min, the second stage is started, and the remaining 60% of H2O2 is slowly injected in a linear increment over 40 minutes.
[0031] During the reaction, an online pH meter installed at the outlet of the reactor in the middle section monitors the pH value of the reaction solution in real time, controlling it within the range of 1.5 to 2.5. The reaction system is carried out under acidic conditions (pH 1.5 to 2.5), which effectively suppresses the hydrolysis side reaction of dibromocyanoacetamide and ensures the chemical stability of the product under high temperature conditions. An online dissolved oxygen sensor and pressure transmitter monitor the gas generation in the reactor in real time. Once an abnormal increase in pressure is detected, exceeding the set threshold of 0.05 MPa in this embodiment, the PLC system automatically stops the H2O2 feeding and starts the emergency cooling program. During this process, cyanoacetamide undergoes an electrophilic bromination reaction with liquid bromine to generate dibromocyanoacetamide. The by-product HBr is immediately oxidized in situ by H2O2 to regenerate Br2, realizing a closed-loop cycle of bromine species. In this embodiment, the residual concentration of cyanoacetamide in the outlet reaction solution is <0.1%, and the conversion rate is ≥99.8%.
[0032] S3 Rapid Cooling Crystallization: After the reaction, the high-temperature clarified liquid is pumped to a plate heat exchanger via a corrosion-resistant diaphragm pump, where it is initially cooled to 60°C using circulating cooling water. It then enters a rapid cooling device with built-in spiral coils, through which -5°C chilled brine is introduced. The fluid inside the coils achieves extremely rapid heat transfer under highly turbulent conditions, completing the rapid cooling phase within 18 seconds, with an average cooling rate of 2.2°C / s. The final outlet temperature stabilizes at 20±1°C. The crystallizer is a 2m³ jacketed stainless steel container with a scraper-type agitator at the bottom to prevent crystal sedimentation and adhesion to the walls.
[0033] S4 Centrifugation and Drying: The crystallized slurry was fed into a horizontal screw centrifuge at a flow rate of 30 L / min for continuous solid-liquid separation at 3000 rpm. The resulting wet product had a moisture content of approximately 8%. After washing once with a small amount of deionized water, it was transferred to a vacuum rake dryer and dried for 4 hours to constant weight. This batch yielded 692 kg of DBNPA solid product, with a purity of 99.3% as determined by HPLC, a total yield of 96.2% based on cyanoacetamide, and a byproduct content of 0.25%.
[0034] S5 Mother Liquor Purification and Recycling: The mother liquor obtained from centrifugation undergoes the following treatments: filtration through a 0.45μm polyvinylidene fluoride microporous membrane to remove particulate impurities; the filtrate is then passed through an adsorption column packed with strongly basic anion exchange resin to remove trace organic byproducts; the mother liquor composition is monitored in real time using an online conductivity meter and a UV absorption detector, and the PLC system automatically replenishes fresh deionized water based on feedback signals to stabilize the pH of the circulating mother liquor at 5.7 and TOC content fluctuation <±3%. The treated mother liquor is pumped back to the raw material pre-dissolution process and used as a solvent medium for the dissolution and reaction of the next batch of cyanoacetamide. After 10 consecutive batches, the product purity remained within the range of 99.1%–99.4%, the yield fluctuation was <1%, and the chemical composition of the mother liquor showed no significant change, proving that the recycling system is stable and reliable.
[0035] Preparation of Solution S6: Take 1000 kg of dibromocyanoacetamide solid product, add 5580 kg of the purified circulating mother liquor obtained in step S5, 120 kg of the composite co-solvent polyethylene glycol 400 (PEG-400), and 60 kg of dipropylene glycol (DPG), and stir in a mixing tank for 30 minutes to dissolve. Then add 1.2 kg of sodium benzoate and continue stirring for 15 minutes until completely dispersed and uniform. The resulting solution formulation has an effective DBNPA content of 14.8%, pH=5.8, and is a pale yellow transparent liquid. Accelerated stability testing showed no precipitation, turbidity, or stratification, demonstrating excellent storage stability of the formulation.
[0036] Example 2
[0037] This embodiment addresses the issues of uneven temperature distribution and localized overheating and product degradation in tubular reactors by optimizing the reactor structure and temperature control system. All other process parameters remain the same as in Example 1.
[0038] The tubular reactor features an independent heat transfer oil circulation temperature control loop in its three heating sections. The front and rear sections are heated with heat transfer oil, while the middle section is equipped with an electric heating belt and infrared temperature measurement for real-time feedback temperature control with an accuracy of ±0.5℃. A 0.8m long adiabatic temperature buffer transition section is added between each heating section to eliminate thermal shock caused by direct contact between hot and cold fluids and reduce metal stress in the pipeline.
[0039] Operational test results: Byproduct content decreased to 0.24%, total product yield increased to 96.5%, and quality differences caused by temperature fluctuations were further reduced; no material adhered to the tube wall or coked during 15 consecutive batches of operation, and the reactor cleaning cycle was extended by 3 times.
[0040] Example 3
[0041] The difference between this embodiment and Embodiment 1 is that the hydrogen peroxide is added in a single, full dose to verify the superiority of the gradient batch injection strategy.
[0042] A 30% hydrogen peroxide aqueous solution was injected into the reactor in a single, complete injection within 5 minutes of the reaction initiation. All other operating conditions were the same as in Example 1.
[0043] The results showed that a significant exothermic peak was observed during the reaction, with the peak temperature rise rate in the jacketed loop reaching 1.8 °C / min, and the pressure inside the reactor briefly increasing by 0.03 MPa. The hydrogen peroxide decomposition rate increased to 7.2%, while the bromination-hydrogenation efficiency decreased to 91%. The purity of the obtained product was 98.7%, the yield was 93.5%, and the byproduct content increased to 0.6%. This example verifies that adding all hydrogen peroxide at once not only poses safety hazards but also leads to a decrease in oxidation efficiency and product quality, thus validating the necessity and superiority of the gradient batch injection strategy.
[0044] Example 4
[0045] The difference between this embodiment and Embodiment 1 lies in the adjustment of the cooling crystallization process parameters.
[0046] A conventional jacketed cooling method was used, with the cooling water temperature at 15°C. The high-temperature reaction liquid was slowly cooled from 83°C to 20°C within 15 minutes, with an average cooling rate of approximately 0.07°C / s. The remaining operating conditions were the same as in Example 1.
[0047] The results showed that the obtained DBNPA crystals had irregular morphology and obvious agglomeration. During centrifugation, the filter cloth frequently clogged, the moisture content of the wet product rose to 15%, and the crystal yield decreased by 4.5 percentage points compared to Example 1. This example verifies that the rapid cooling crystallization process plays a crucial role in obtaining high-quality crystals with uniform particle size and easy separation.
[0048] Example 5
[0049] The difference between this embodiment and Example 1 is that no composite cosolvent is added to the solution formulation.
[0050] Take 1000 kg of purified mother liquor and add only 0.1% sodium benzoate as a stabilizer; do not add PEG-400 / DPG composite cosolvent. All other operating conditions are the same as in Example 1.
[0051] The results showed that the obtained formulation became slightly turbid after two months of storage at room temperature, and a trace amount of white precipitate was visible at the bottom after the third month. HPLC analysis showed that the DBNPA content decreased by 4.8%, and the pH decreased from the initial 5.8 to 4.9. This comparative example demonstrates that the PEG-400 and DPG composite cosolvent plays an irreplaceable role in maintaining the solubility of DBNPA in the aqueous phase and the long-term storage stability of the formulation.
[0052] Example 6
[0053] This example verifies the effect of different cyanoacetamide pre-solution concentrations on the reaction effect.
[0054] Pre-solutions of cyanoacetamide with mass concentrations of 20%, 25%, and 30% were prepared, with all other operating conditions identical to those in Example 1. The results are shown in the table below:
[0055] Cyanacetamide concentration (%) Reaction residence time (min) Product purity (%) Overall yield (%) 20 90 99.4 95.1 25 80 99.3 96.2 30 75 99.0 95.5
[0056] The results showed that 25% was the optimal concentration of cyanoacetamide pre-solution, balancing reaction efficiency, product purity, and overall yield. While a slightly higher purity was achieved with too low a concentration, equipment capacity decreased; conversely, a higher concentration resulted in increased system viscosity, limiting mass transfer and reducing both product purity and overall yield.
[0057] The present invention provides an industrial production method for dibromocyanoacetamide solution. Using cyanoacetamide as a raw material, a continuous bromination reaction is carried out with liquid bromine and hydrogen peroxide in a multi-stage series tubular reactor under high-temperature homogeneous conditions, achieving a closed-loop recycling of bromine with a total bromine utilization rate approaching 100%. The reaction solution is rapidly cooled and crystallized to obtain high-purity DBNPA crystals with uniform particle size. The centrifuged mother liquor is purified by microfiltration and resin adsorption before recycling, supporting continuous operation across multiple batches. This invention features high bromine utilization, high production efficiency, stable product quality, and environmental friendliness, making it suitable for large-scale, continuous, and clean production of DBNPA.
[0058] The above embodiments are merely preferred embodiments of the present invention and are not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, improvements, etc., made by those skilled in the art based on the above description within the spirit and principles of the present invention should be included within the scope of protection of the present invention. The scope of protection of the present invention is defined by the appended claims.
Claims
1. An industrial method for producing a dibromocyanoacetamide solution, characterized in that: Includes the following steps: S1 Raw Material Pre-dissolution: Dissolve cyanoacetamide in water to prepare a pre-solution with a mass concentration of 20% to 30%; S2 High-Temperature Homogeneous Continuous Bromination Reaction: The pre-solution, liquid bromine, and hydrogen peroxide aqueous solution are simultaneously and continuously injected into a tubular reactor, and the bromination reaction is carried out under homogeneous aqueous solution conditions at 70–87°C. The molar amount of liquid bromine added is 1.0–1.3 times the molar amount of cyanoacetamide, and the amount of liquid bromine added is the net amount after deducting the amount of bromine recovered from in-situ oxidation and regeneration by hydrogen peroxide. The molar amount of hydrogen peroxide added is 1.0–1.1 times the amount of byproduct hydrobromic acid theoretically required for consumption. The tubular reactor includes a first heating zone, a second heating zone, and a third heating zone arranged sequentially along the axial direction. The temperature of the first heating zone is 70–80°C, the temperature of the second heating zone is 83–87°C, and the temperature of the third heating zone is 78–85°C. During the reaction, hydrogen peroxide in-situ oxidizes and regenerates the byproduct hydrobromic acid into bromine, achieving a closed-loop bromine cycle. The total residence time of the reaction is 60–90 minutes. S3 Rapid Cooling Crystallization: The high-temperature clarified liquid after the reaction is completed is subjected to two-stage cooling treatment: first, it is initially cooled to 55-65℃ by a heat exchanger, and then rapidly cooled from 55-65℃ to 18-22℃ within 15-25 seconds. The cooling rate of the rapid cooling stage is 1.5-3.0℃ / s, which induces the selective crystallization of dibromocyanoacetamide. S4 Centrifugation and Drying: The crystallized slurry is centrifuged to separate the solid and liquid components, and wet dibromocyanoacetamide is obtained. After washing and drying, a solid product is obtained. S5 Mother liquor purification and recycling: The mother liquor obtained by centrifugation is purified by microfiltration and resin adsorption in sequence and then divided into two parts. The first part is recycled for the pre-dissolution of raw materials in the next batch of step S1 and the reaction medium in step S2; the second part is used for the preparation of solution formulation in step S6. S6 Solution Formulation Preparation: Take the DBNPA solid product obtained in step S4, dissolve it in the purified circulating mother liquor after step S5, add a composite co-solvent and a stabilizer, and prepare a solution formulation; the composite co-solvent is composed of polyethylene glycol 400 and dipropylene glycol mixed in a mass ratio of (1.5~2.5):1, and the total amount added is 15%~20% of the mass of dibromocyanoacetamide; the stabilizer is sodium benzoate, and the amount added is 0.05%~0.2% of the total mass of the formulation.
2. The industrial production method of a dibromocyanoacetamide solution according to claim 1, characterized in that: The temperature of the first heating zone is 75℃, the temperature of the second heating zone is 85±2℃, and the temperature of the third heating zone is 82℃; the length of the first heating zone accounts for 25% to 35% of the total length of the reactor, the length of the second heating zone accounts for 35% to 45%, and the length of the third heating zone accounts for 25% to 35%.
3. The industrial production method of a dibromocyanoacetamide solution according to claim 1, characterized in that: In step S2, the hydrogen peroxide is added in the form of an aqueous solution with a mass concentration of 25% to 35%, using a gradient batch injection method: in the first stage, 35% to 45% of the total feed amount is added within 5 to 15 minutes after the reaction starts, and after the exothermic reaction tends to stabilize, the remaining part is added in a linear increment within 30 to 50 minutes in the second stage.
4. The industrial production method of a dibromocyanoacetamide solution according to claim 1, characterized in that: In step S3, the rapid cooling crystallization adopts a dynamic cooling system consisting of a plate heat exchanger and a spiral coil cooling device connected in series; the high-temperature reaction liquid is first cooled to 55-65°C by the plate heat exchanger, and then rapidly cooled to 18-22°C by the spiral coil cooling device under the action of chilled brine; the Reynolds number Re in the tube is greater than 8000.
5. The industrial production method of a dibromocyanoacetamide solution according to claim 1, characterized in that: In step S3, by controlling the cooling rate and supersaturation, the median particle size D50 of the obtained dibromocyanoacetamide crystals is made to be 80-120 μm, and the particle size distribution coefficient Span < 1.
2.
6. The industrial production method of a dibromocyanoacetamide solution according to claim 1, characterized in that: In step S5, the microporous filtration uses a microporous filter membrane with a pore size of 0.2 to 0.8 μm; the resin adsorption uses a strongly basic anion exchange resin; the pH of the circulating mother liquor is controlled at 5.0 to 6.5, and the total organic carbon content fluctuates by less than ±5%; the mother liquor supports continuous recycling for at least 10 batches.
7. The industrial production method of a dibromocyanoacetamide solution according to claim 1, characterized in that: The mass ratio of polyethylene glycol 400 to dipropylene glycol is 2:1, and the total amount added is 18% of the mass of dibromocyanoacetamide; the amount of sodium benzoate added is 0.1% of the total mass of the formulation; the effective dibromocyanoacetamide content in the resulting solution formulation is 12% to 18%.
8. The industrial production method of a dibromocyanoacetamide solution according to claim 1, characterized in that: The inner wall of the tubular reactor is made of 316L stainless steel, titanium, or enamel, with a surface roughness Ra≤0.8μm; the reactor is equipped with spiral guide vanes; and a temperature buffer transition section is provided between each heating zone.
